Vitals Groenlipmosselolie-NZ 60 softgels - unique phospholipid complex from green lipped mussel with ahiflower oil

• not made from the more usual green lip mussel powder
• contains superior green lipped mussel oil, made by means of CO2 extraction
• from pristine waters of Marlborough Sounds in Nieuw-Zeeland
• unique combination of fats with precious elements
• supplemented with ahiflower oil, with a combination of omega-3 and omega-6 fatty acids
• stabilized with powerful antioxidants

GlycOmega-Oil (Greenshell™ mussel oil) is a 100% natural supplement and is the only product that not only contains health-promoting omega-3 fatty acids DHA and EPA (the two essential fatty acids found in most ordinary fish oil products), but also a total of 30 essential fatty acids. This diverse combination of essential fatty acids makes GlycOmega-Oil unique. It is so potent that only a very small dose is required for it to be effective. It is safe, has no known drug interactions, and comes in small easy-to-swallow soft-gel caps. GlycOmega-Oil enables you to return to the healthy lifestyle you enjoyed prior to the limiting effects of joint pain and inflammation. Research has shown it to be critical to joint health, respiratory health, cardiovascular health, HDL and triglyceride levels.

Green lipped mussels are grown in the famous Marlborough Sounds region at the southernmost island of New Zealand, is strictly monitored and only delivers mussels that meet the highest quality demands.

background reading

Research has shown the omega-3s in Green Lipped Mussel Oil to be critical to joint health, respiratory health, cardiovascular health, cholesterol, HDL and triglyceride levels. Omega-6s and other types of fats in our diets leave our cell membranes rich in precursors associated with inflammatory processes, which can lead to arthritis, asthma, heart disease, depression, and psoriasis. Scientific research indicates that we need to reduce omega-6s and increase omega-3s to improve our health.

For generations, the native coastal Maori population of New Zealand has consumed raw New Zealand green lipped mussels as a primary part of their diet. this unique mussel is known scientifically as ‘Perna canaliculus’.
For centuries, it has provided an excellent source of protein, vitamins, minerals and extremely valuable omega-3 fatty acids. For many hundreds of years, the Maoris would harvest the mussels growing naturally on the seashores and eat them raw.
Even though they saw the mussel as an important part of their diet, they did not realise the benefits they were gaining. the green lipped mussel possesses a profile of omega-3 essential fatty acids that are unique to its species.the presence of this rich source of essential fatty acids provides the mussel with potent soothing action.
Tthe observation that Maoris who regularly consumed green shell mussels suffered less arthritis than their inland relatives, led to the research and development of marketable antiarthritic products.
The green shell mussel (Perna canaliculus) is also called green-lipped mussel or New Zealand mussel. Green shell mussel products are widely used in dietary supplements as anti-inflammatory agents to ight asthma, arthritis, pain, and inflammation.
The omega-3 fatty adds in the mussel are responsible for the anti-inflammatory effects.

Green Lipped Mussel Oil is a unique marine lipid group comprising a unique combination of different non-polar lipid groups and omega-3 polyunsaturated fatty acids which are extracted from the New Zealand green-lipped mussel (Perna Canaliculus) by supercritical fluid extraction process using liquidified C02.
Glycomega-oil is only processed from live cold opened greenshell mussel meat, which is blended with a botanical anti-oxidant to stabilize the omega-3 and lipid fraction.
This unique marine green-lipped mussel oil product has been exposed to critical review by many research institutions worldwide and is proven to have significant anti-inflammatory activity in vitro in inhibiting leukotriene synthesis and in vivo by markedly reducing the severity of adjuvant-induced polyarthritis in rat models. Various publications have been released confirming these results and the recent completion of a human double-blind study conducted at the Glasgow Hospital in Scotland also confirmed these results.